Skip to content

N Antiserum to C1 Inhibitor

by Behring Diagnostics, Inc. 510(k)

Active United States

510(k) K960257

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK960257 Date1 Aug 1996ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 11 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DBA
Device Class
Class II
Regulation
21 CFR Part 866.5250
Advisory Committee
Immunology
FDA Decision
SESE Substantially Equivalent

Other devices from Behring Diagnostics, Inc.

See all devices from Behring Diagnostics, Inc. →